Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Gullestad

Showing results (151-160 of 382) with videos related to

Pageof 39
Sort By:
Pregnancy Hypertension|November 25, 2015
Elevated inflammatory markers in preeclamptic pregnancies, but no relation to systemic arterial stiffnessMette-Elise Estensen, Guro Grindheim, Espen W Remme, et al.
Transplantation|February 24, 2017
Effect of Calcineurin Inhibitor-Free, Everolimus-Based Immunosuppressive Regimen on Albuminuria and Glomerular Filtration Rate After Heart TransplantationLærke Marie Nelson, Arne Kristian Andreassen, Bert Andersson, et al.
European Journal of Preventive Cardiology|June 5, 2012
Muscular exercise capacity and body fat predict VO(2peak) in heart transplant recipientsKari Nytrøen, Lene Annette Rustad, Einar Gude, et al.
Transplantation|July 14, 2007
Depressive symptoms and all-cause mortality after heart transplantationOdd E Havik, Borge Sivertsen, Anne Relbo, et al.
European Journal of Heart Failure|August 7, 2013
Inflammatory cytokines in chronic heart failure: interleukin-8 is associated with adverse outcome. Results from CORONAStåle H Nymo, Johannes Hulthe, Thor Ueland, et al.
American Heart Journal|June 7, 2011
Prognostic value of cardiac troponin T in patients with moderate to severe heart failure scheduled for cardiac resynchronization therapyMarit Aarones, Lars Gullestad, Svend Aakhus, et al.
European Journal of Preventive Cardiology|February 16, 2017
Medical and psychosocial factors and unfavourable low-density lipoprotein cholesterol control in coronary patientsJohn Munkhaugen, Elise Sverre, Jan E Otterstad, et al.
Clinical Cardiology|May 4, 2004
Effects of conventional and aggressive statin treatment on markers of endothelial function and inflammationAina Hognestad, Pål Aukrust, Ragnhild Wergeland, et al.
Journal of the American Society of Hypertension : JASH|November 13, 2017
Optimal blood pressure control after coronary events: the challenge remainsElise Sverre, Kari Peersen, Jan Erik Otterstad, et al.
Scandinavian Cardiovascular Journal : SCJ|October 25, 2011
Differential effects of metoprolol and atenolol to neuropeptide Y blockade in coronary artery diseaseLars Gullestad, John Pernow, Thorvald Bjurö, et al.
Pageof 39

Showing results (151-160 of 382) with videos related to

Sort By:
Pageof 39
Pregnancy Hypertension|November 25, 2015
Elevated inflammatory markers in preeclamptic pregnancies, but no relation to systemic arterial stiffnessMette-Elise Estensen, Guro Grindheim, Espen W Remme, et al.
Transplantation|February 24, 2017
Effect of Calcineurin Inhibitor-Free, Everolimus-Based Immunosuppressive Regimen on Albuminuria and Glomerular Filtration Rate After Heart TransplantationLærke Marie Nelson, Arne Kristian Andreassen, Bert Andersson, et al.
European Journal of Preventive Cardiology|June 5, 2012
Muscular exercise capacity and body fat predict VO(2peak) in heart transplant recipientsKari Nytrøen, Lene Annette Rustad, Einar Gude, et al.
Transplantation|July 14, 2007
Depressive symptoms and all-cause mortality after heart transplantationOdd E Havik, Borge Sivertsen, Anne Relbo, et al.
European Journal of Heart Failure|August 7, 2013
Inflammatory cytokines in chronic heart failure: interleukin-8 is associated with adverse outcome. Results from CORONAStåle H Nymo, Johannes Hulthe, Thor Ueland, et al.
American Heart Journal|June 7, 2011
Prognostic value of cardiac troponin T in patients with moderate to severe heart failure scheduled for cardiac resynchronization therapyMarit Aarones, Lars Gullestad, Svend Aakhus, et al.
European Journal of Preventive Cardiology|February 16, 2017
Medical and psychosocial factors and unfavourable low-density lipoprotein cholesterol control in coronary patientsJohn Munkhaugen, Elise Sverre, Jan E Otterstad, et al.
Clinical Cardiology|May 4, 2004
Effects of conventional and aggressive statin treatment on markers of endothelial function and inflammationAina Hognestad, Pål Aukrust, Ragnhild Wergeland, et al.
Journal of the American Society of Hypertension : JASH|November 13, 2017
Optimal blood pressure control after coronary events: the challenge remainsElise Sverre, Kari Peersen, Jan Erik Otterstad, et al.
Scandinavian Cardiovascular Journal : SCJ|October 25, 2011
Differential effects of metoprolol and atenolol to neuropeptide Y blockade in coronary artery diseaseLars Gullestad, John Pernow, Thorvald Bjurö, et al.
Pageof 39